Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
21st Oct 201912:30 pmRNSDirector/PDMR Shareholding
17th Oct 20193:30 pmRNSHolding(s) in Company
3rd Oct 20192:15 pmRNSDirector/PDMR Shareholding
2nd Oct 20193:43 pmRNSHolding(s) in Company
2nd Oct 201912:15 pmRNSDirector/PDMR Shareholding
1st Oct 20191:50 pmRNSBlock listing Interim Review
30th Sep 20195:09 pmRNSHolding(s) in Company
30th Sep 201912:15 pmRNSTotal Voting Rights
26th Sep 20197:00 amRNSPre-Close Trading Update
23rd Sep 20193:15 pmRNSDirector/PDMR Shareholding
17th Sep 20192:15 pmRNSAdditional Listing
11th Sep 201912:00 pmRNSNotice of Pre-Close Trading Statement
30th Aug 201911:45 amRNSTotal Voting Rights
27th Aug 20191:00 pmRNSDirector/PDMR Shareholding
31st Jul 20191:28 pmRNSVoting Rights and Capital
31st Jul 20197:00 amRNSThird Quarter Trading Update
29th Jul 201911:15 amRNSDirector/PDMR Shareholding
18th Jul 201912:00 pmRNSNotice of Third Quarter Trading Update
3rd Jul 201911:30 amRNSAdditional Listing
1st Jul 20194:00 pmRNSDirector/PDMR Shareholding
28th Jun 20192:00 pmRNSTotal Voting Rights
24th Jun 201911:30 amRNSDirector/PDMR Shareholding
24th Jun 201911:30 amRNSDirector/PDMR Shareholding
3rd Jun 20193:15 pmRNSDirector/PDMR Shareholding
31st May 201910:30 amRNSTotal Voting Rights
29th May 20194:04 pmRNSHolding(s) in Company
23rd May 20197:00 amRNSHalf Year Results
7th May 20192:30 pmRNSDirector/PDMR Shareholding
1st May 20193:30 pmRNSHolding(s) in Company
30th Apr 201911:45 amRNSTotal Voting Rights
26th Apr 201910:30 amRNSNotice of Half Year Results
12th Apr 201912:15 pmRNSDirector/PDMR Shareholding
8th Apr 20192:00 pmRNSDirector/PDMR Shareholding
1st Apr 201910:30 amRNSTotal Voting Rights
1st Apr 201910:30 amRNSBlock listing Interim Review
20th Mar 20199:30 amRNSHolding(s) in Company
15th Mar 201910:30 amRNSChange to Director's Details - Jane Moriarty
11th Mar 20194:00 pmRNSDirector/PDMR Shareholding
28th Feb 201912:00 pmRNSTotal Voting Rights
27th Feb 20191:48 pmRNSBoard Appointments
11th Feb 201912:30 pmRNSDirector/PDMR Shareholding
6th Feb 20199:30 amRNSChange to Director's Details - Colin Rutherford
23rd Jan 201910:29 amRNSResult of Annual General Meeting
14th Jan 20194:00 pmRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSFirst Quarter Trading Update
7th Jan 201912:00 pmRNSNotice of first quarter trading update
2nd Jan 20193:13 pmRNSTotal Voting Rights
17th Dec 20183:49 pmRNSDirector/PDMR Shareholding
17th Dec 201812:00 pmRNSAnnual Report 2018
14th Dec 201810:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.